Content area
Novaliq GmbH - Pharmaceuticals and Healthcare Product Pipeline
Summary
Novaliq GmbH (Novaliq) is a pharmaceutical company that develops transformational ocular therapies. It develops the new drug category of water-free topical eye therapies called EyeSol. The company offers products in the disease area of dry eye disease, glaucoma, dermatology and diabetic retinopathy.
This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.
This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Details
Subject
Business indexing term
Location
Company
Title
Novaliq GmbH
Number of pages
50
Publication year
2025
Publication date
2025
Place of publication
London
Country of publication
United Kingdom
Publication subject
Source type
Report
Language of publication
English
Document type
Company Profile
Document feature
Tables; Graphs; Company description; Company financials; Company competitors; Company SWOT
ProQuest document ID
2453674795
Document URL
https://www.proquest.com/reports/novaliq-gmbh/docview/2453674795/se-2?accountid=208611
Copyright
Copyright GlobalData plc 2025
Last updated
2025-08-25
Database
ProQuest One Academic